ophthalmologyОфтальмологияOphthalmology in Russia1816-50952500-0845Ophthalmology10.18008/1816-5095-2019-4-487-493ophthalmology-1082Research ArticleКЛИНИЧЕСКИЕ И ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯCLINICAL & EXPERIMENTAL RESEARCHОсобенности зрительных нарушений при тромбофилии ЛейденаClinical Features of Visual Disturbances in Leiden ThrombophiliaИойлеваЕ. Э.IoylevaE. E.

доктор медицинских наук, ученый секретарь, профессор кафедры глазных болезней

Бескудниковский бульвар, 59а, Москва, 127486, Российская Федерация

ул. Делегатская, 20/1, Москва, 127473, Российская Федерация

MD, PhD, professor

Beskudnikovsky blvd, 59a, Moscow, 127486, Russian Federation

Delegatskaya str., 20, build. 1, Moscow, 127473, Russian Federation

ЗиновьеваА. В.Zinov’evaA. V.

ординатор

ул. Делегатская, 20/1, Москва, 127473, Российская Федерация

resident

Delegatskaya str., 20, build. 1, Moscow, 127473, Russian Federation

aleksandra.r@live.ruФГАУ «МНТК “Микрохирургия глаза” им. акад. С.Н. Федорова» Министерства здравоохранения Российской Федерации, ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Министерства здравоохранения Российской ФедерацииРоссияThe S. Fyodorov Eye Microsurgery Federal State Institution, A.I. Yevdokimov Moscow State University of Medicine and DentistryRussian FederationФГАУ «МНТК “Микрохирургия глаза” им. акад. С.Н. Федорова» Министерства здравоохранения Российской ФедерацииРоссияA.I. Yevdokimov Moscow State University of Medicine and DentistryRussian Federation201925122019164487493Copyright &#x00A9; Иойлева Е.Э., Зиновьева А.В., 20192019Иойлева Е.Э., Зиновьева А.В.Ioyleva E.E., Zinov’eva A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.ophthalmojournal.com/opht/article/view/1082тромбофилияфактор Лейденатромбоз центральной вены сетчаткиокклюзия центральной артерии сетчаткипередняя ишемическая нейропатияamaurosis fugaxthrombophiliaLeiden factorthrombosis of the central retinal veinocclusion of the central retinal arteryanterior ischemic neuropathyamaurosis fugaxReferencesSchockman S., Glueck C.J., Hutchins R.K., Patel J., Shah P., Wang P. Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity. Clinical Ophthalmology. 2015;9:591–600. DOI: 10.2147/OPTH.S80714Schockman S., Glueck C.J., Hutchins R.K., Patel J., Shah P., Wang P. Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity. Clinical Ophthalmology. 2015;9:591–600. DOI: 10.2147/OPTH.S80714Nagy V., Takacs L., Steiber Z, Pfliegler G., Berta A. Thrombophilic screening in retinal artery occlusion patients. Clinical Ophthalmology. 2008;2(3):557–561.Nagy V., Takacs L., Steiber Z, Pfliegler G., Berta A. Thrombophilic screening in retinal artery occlusion patients. Clinical Ophthalmology. 2008;2(3):557–561.Pianka P., Almog Y., Man O., Goldstein M., Sela B.A., Loewenstein A. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 2000;107(8):1588–1592. DOI: 10.1016/S0161‑6420(00)00181‑0Pianka P., Almog Y., Man O., Goldstein M., Sela B.A., Loewenstein A. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 2000;107(8):1588–1592. DOI: 10.1016/S0161‑6420(00)00181‑0Salomon O., Huna‑Baron R., Moisseiev J., Rosenberg N., Rubovitz A., Steinberg D.M., Davidson J., Sela B.A., Seligsohn U. Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source. Eye. 2001;15(4):511–514. DOI: 10.1038/eye.2001.164Salomon O., Huna‑Baron R., Moisseiev J., Rosenberg N., Rubovitz A., Steinberg D.M., Davidson J., Sela B.A., Seligsohn U. Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source. Eye. 2001;15(4):511–514. DOI: 10.1038/eye.2001.164Murin S., Marelich G.P., Arroliga A.C., Matthay R.A. Hereditary Thrombophilia and Venous Thromboembolism. American Journal of Respiratory and Critical Care Medicine. 1998;158(5):1369–1373. DOI: 10.1164/ajrccm.158.5.9712022Murin S., Marelich G.P., Arroliga A.C., Matthay R.A. Hereditary Thrombophilia and Venous Thromboembolism. American Journal of Respiratory and Critical Care Medicine. 1998;158(5):1369–1373. DOI: 10.1164/ajrccm.158.5.9712022De Stefano V., Chiusolo P., Paciaroni K., Leone G. Epidemiology of factor V Leiden: clinical implications. Seminars in Thrombosis and Hemostasis. 1998;24(4):367–379. DOI: 10.1055/s‑2007‑996025De Stefano V., Chiusolo P., Paciaroni K., Leone G. Epidemiology of factor V Leiden: clinical implications. Seminars in Thrombosis and Hemostasis. 1998;24(4):367–379. DOI: 10.1055/s‑2007‑996025Kujovich J.L. Factor V Leiden thrombophilia. Genetics IN Medicine. 2011;13:1–16. DOI: 10.1097/GIM.0b013e3181faa0f2Kujovich J.L. Factor V Leiden thrombophilia. Genetics IN Medicine. 2011;13:1–16. DOI: 10.1097/GIM.0b013e3181faa0f2Nagy V., Facsko A., Takacs L., Balazs E., Berta A., Balogh I., Edes I., Czuriga I., Pfliegler G. Activated protein C resistance in anterior ischaemic optic Neuropathy. Acta Ophthalmologica Scandinavica. 2004;82:140–143. DOI: 10.1111/j.1600‑0420.2004.00226.xNagy V., Facsko A., Takacs L., Balazs E., Berta A., Balogh I., Edes I., Czuriga I., Pfliegler G. Activated protein C resistance in anterior ischaemic optic Neuropathy. Acta Ophthalmologica Scandinavica. 2004;82:140–143. DOI: 10.1111/j.1600‑0420.2004.00226.xGottlieb J.L., Blice J.P., Mestichelli B., Konkle B.A., Benson W.E. Activated Protein C Resistance, Factor V Leiden, and Central Retinal Vein Occlusion in Young Adults. Archives of Ophthalmology. 1998;116(5):577–579. DOI: 10.1001/archopht.116.5.577Gottlieb J.L., Blice J.P., Mestichelli B., Konkle B.A., Benson W.E. Activated Protein C Resistance, Factor V Leiden, and Central Retinal Vein Occlusion in Young Adults. Archives of Ophthalmology. 1998;116(5):577–579. DOI: 10.1001/archopht.116.5.577Dhar‑Munshi S., Ayliffe W.H., Jayne D. Branch Retinal Arteriolar Occlusion Associated with Familial Factor V Leiden Polymorphism and Positive Rheumatoid Factor. Archives of Ophthalmology. 1999;117(7):978–979.Dhar‑Munshi S., Ayliffe W.H., Jayne D. Branch Retinal Arteriolar Occlusion Associated with Familial Factor V Leiden Polymorphism and Positive Rheumatoid Factor. Archives of Ophthalmology. 1999;117(7):978–979.Rosendaal F.R., Siscovick D.S., Schwartz S.M., Beverly R.K., Psaty B.M., Longstreth W.T. Jr, Raghunathan T.E., Koepsell T.D., Reitsma P.H. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood. 1997;89:2817–2821.Rosendaal F.R., Siscovick D.S., Schwartz S.M., Beverly R.K., Psaty B.M., Longstreth W.T. Jr, Raghunathan T.E., Koepsell T.D., Reitsma P.H. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood. 1997;89:2817–2821.Mannucci P.M. Fine particulate: it matters. Journal of Thrombosis and Haemostasis. 2010;8:659–661. DOI: 10.1111/j.1538‑7836.2010.03804.xMannucci P.M. Fine particulate: it matters. Journal of Thrombosis and Haemostasis. 2010;8:659–661. DOI: 10.1111/j.1538‑7836.2010.03804.xMargaglione M., D’Andrea G., Giuliani N., et al. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1751–1756.Margaglione M., D’Andrea G., Giuliani N., et al. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1751–1756.Backhouse O., Parapia L., Mahomed I., Lee D. Familial thrombophilia and retinal vein occlusion. Eye. 2000;14:13–17. DOI: 10.1038/eye.2000.4Backhouse O., Parapia L., Mahomed I., Lee D. Familial thrombophilia and retinal vein occlusion. Eye. 2000;14:13–17. DOI: 10.1038/eye.2000.4Talman T., Scharf J., Meyer E., Lanir N. Miller B., Brenner B. Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations. American Journal of Ophthalmology. 1997;124(5):689–691.Talman T., Scharf J., Meyer E., Lanir N. Miller B., Brenner B. Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations. American Journal of Ophthalmology. 1997;124(5):689–691.Tayyanipour R., Pulido J.S., Postel E.A., Lipkowitz J.L., Pisciotta A., Braza E. Arterial vascular occlusion associated with factor V Leiden gene mutation. Retina. 1998;18:376–377.Tayyanipour R., Pulido J.S., Postel E.A., Lipkowitz J.L., Pisciotta A., Braza E. Arterial vascular occlusion associated with factor V Leiden gene mutation. Retina. 1998;18:376–377.Bessero A.C., Borruat F.X. Visual dysfunction and arterial occlusion: is there an association with factor V Leiden mutation? Four case reports. Journal Francais D’Opthalmologie. 2006;29:43–46.Bessero A.C., Borruat F.X. Visual dysfunction and arterial occlusion: is there an association with factor V Leiden mutation? Four case reports. Journal Francais D’Opthalmologie. 2006;29:43–46.Frye R.E. Transient Visual Loss Associated with the Factor V Leiden Mutation. North American Journal of Medicine and Science. 2017;10(2):61–64. DOI: 10.7156/najms.2017.1002061Frye R.E. Transient Visual Loss Associated with the Factor V Leiden Mutation. North American Journal of Medicine and Science. 2017;10(2):61–64. DOI: 10.7156/najms.2017.1002061Cursiefen C., Schonherr U., Schwender S., Grossmann R. Recurrent optic nerve headinfarctions associated with combined factor V Leiden‑ and factor II:G20210A‑mutation. Acta Ophthalmologica Scandinavica. 1999;77:625–627.Cursiefen C., Schonherr U., Schwender S., Grossmann R. Recurrent optic nerve headinfarctions associated with combined factor V Leiden‑ and factor II:G20210A‑mutation. Acta Ophthalmologica Scandinavica. 1999;77:625–627.Lorca‑Barchín J., Medrano‑Martínez V., Francés‑Pont I., Fernández‑Izquierdo S., Mallada‑Frechin J., Piqueras‑Rodríguez L. Non‑Arteritic Anterior Ischemic Optic Neuropathy and Factor V Leiden. Journal of Neurological Disorders. 2015;2(3):303.Lorca‑Barchín J., Medrano‑Martínez V., Francés‑Pont I., Fernández‑Izquierdo S., Mallada‑Frechin J., Piqueras‑Rodríguez L. Non‑Arteritic Anterior Ischemic Optic Neuropathy and Factor V Leiden. Journal of Neurological Disorders. 2015;2(3):303.Пизова Н.В., Степанова М.В. Тромбофилии, связанные с резистентностью к активированному протеину С: генетические полиморфизмы и инсульт. Неврологический журнал. 2012;6:4–11.Pizova N.V., Stepanova M.V. Thrombophilia associated with resistance to activated protein C: genetic polymorphisms and stroke. Neurological Journal = Nevrologicheskiy zhurnal. 2012;6:4–11 (In Russ.)Kapiotis S., Quehenberger P., Jilma B., Handler S., Pabinger‑Fasching I., Mannhalter C., Speiser W. Improved characteristics of aPC‑resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma. American Journal of Clinical Pathology. 1996;106:588–593. DOI: 10.1093/ajcp/106.5.588Kapiotis S., Quehenberger P., Jilma B., Handler S., Pabinger‑Fasching I., Mannhalter C., Speiser W. Improved characteristics of aPC‑resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma. American Journal of Clinical Pathology. 1996;106:588–593. DOI: 10.1093/ajcp/106.5.588Grody W.W., Griffin J.H., Taylor A.K., Korf B.R., Heit J.A. Factor V Leiden Working Group. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genetics in Medicine. 2001;3:139–148. DOI: 10.109700125817‑200103000‑00009Grody W.W., Griffin J.H., Taylor A.K., Korf B.R., Heit J.A. Factor V Leiden Working Group. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genetics in Medicine. 2001;3:139–148. DOI: 10.109700125817‑200103000‑00009Press R.D., Bauer K.A., Kujovich J.L., Heit J.A. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Archives of Pathology & Laboratory Medicine. 2002;126(11):1304–1318. DOI: 10.1043/0003‑9985(2002)126<1304:CUOFVL>2.0.CO;2Press R.D., Bauer K.A., Kujovich J.L., Heit J.A. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Archives of Pathology & Laboratory Medicine. 2002;126(11):1304–1318. DOI: 10.1043/0003‑9985(2002)126<1304:CUOFVL>2.0.CO;2

The authors declare that there are no conflicts of interest present.